搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
12 天
FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
16 小时
The FDA Is Launching New Traceability Rules for Added Food Safety — and Everyone Is Confused
On January 20, 2026, the Food and Drug Administration's (FDA) new traceability rules — dubbed the Food Traceability Final ...
9 天
The FDA May Add a Warning Label to Some of Your Favorite Foods
Sometimes navigating a nutrition label can be tricky for folks experiencing a dietary-related illness or just wanting to be ...
2 天
on MSN
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
2 天
精神分裂症治疗的历史性一夜
9月26日,精神分裂症领域迎来历史性一刻,Karuna研发的KarXT获得FDA批准上市。这意味着,百时美施贵宝的百亿豪赌初战告捷。去年12月22日,百时美施贵宝豪掷140亿美元收购Karuna,为的就是KarXT。
MassDevice
12 天
FDA approves expanded label for Boston Scientific Ingevity+ pacing leads
Boston Scientific (NYSE: BSX) received FDA approval to expand the indication for its current-generation Ingevity+ pacing ...
5 天
on MSN
Your Favorite Foods Could Soon Come With a Warning Label, Thanks to the FDA
In February, Vermont senator Bernie Sanders sent a letter to the FDA, urging for strong warning labels on certain foods. Some ...
STAT
3 天
FDA approves schizophrenia drug that could alter how disorder is treated
Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works ...
2 天
on MSN
Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD
Regeneron (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced Friday that the U.S. FDA approved a label expansion for its asthma ...
The Washington Post on MSN
3 天
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
director of FDA’s division of psychiatry, said in a statement. “This approval offers a new alternative to the antipsychotic ...
STAT
2 天
Dispute over Duchenne gene therapy highlights thorny access issues
A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.
2 天
FDA greenlights Regeneron’s Dupixent for the treatment of COPD
With an approval based on two pivotal Phase III studies, Dupixent is now the first-ever biologic indicated for treating COPD.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈